Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Eiken Chemical Co., Ltd. ( (JP:4549) ).
Eiken Chemical Co., Ltd. has announced its opposition to a shareholder proposal from AVI Japan Opportunity Trust PLC, which includes amendments to the articles of incorporation and a buyback of shares. The company emphasizes its commitment to strengthening its governance structure with a board composed mainly of independent directors, aiming to enhance corporate value and shareholder value in the medium to long term. The board believes that maintaining decision-making authority on share buybacks and earnings appropriation within the board, rather than expanding shareholder rights, aligns with its strategic governance framework.
More about Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. operates in the chemical industry, focusing on the development and production of diagnostic reagents and equipment. The company is known for its innovative approach to enhancing healthcare through its products and services.
Average Trading Volume: 105,556
Technical Sentiment Signal: Hold
Current Market Cap: Yen64.09B
See more insights into 4549 stock on TipRanks’ Stock Analysis page.